Crossmark

Precision analysis of a quantitative CT liver surface nodularity score

Crossref DOI link: https://doi.org/10.1007/s00261-018-1617-x

Published Online: 2018-04-26

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smith, Andrew

Varney, Elliot

Zand, Kevin

Lewis, Tara

Sirous, Reza

York, James

Florez, Edward

Abou Elkassem, Asser

Howard-Claudio, Candace M.

Roda, Manohar

Parker, Ellen

Scortegagna, Eduardo

Joyner, David

Sandlin, David

Newsome, Ashley

Brewster, Parker

Lirette, Seth T.

Griswold, Michael
License Information

Text and Data Mining valid from 2018-04-26
More Information

Article History

First Online: 26 April 2018

Compliance with ethical standards

:

: None.

: Andrew Smith is the inventor of the technology and has patents pending that are assigned to Liver Nodularity (Jackson, MS), owned by Andrew Smith. Andrew Smith was responsible for study design, analysis, and manuscript preparation but did not participate in measurements. The measurement data were controlled by other team members and the statistician. The University of Mississippi Medical Center has patents pending, is the patent assignee for these patents, and has licensed these patents to Liver Nodularity LLC. There are no other relevant conflicts of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The need for informed consent was waived by the institutional review board for this retrospective chart and imaging review study.